压垮疫苗股的，并不是阿斯利康的无利润定价

Executives from Johnson & Johnson and AstraZeneca Plc testified that they will price their respective potential vaccines at no profit while the pandemic rages on.

强生 和阿斯利康 先表态

"We will not be selling our vaccine at cost, although it is premature for us as we‘re a long way from understanding the cost-basis," Julie Gerberding, chief patient officer for Merck, told the House of Representatives subcommittee on oversight and investigations in a virtual, off-site hearing.
默克 的态度比较机灵鬼，先讨好股东

Pfizer Inc has said the company intends to make a profit from its potential coronavirus vaccine if approved. However, Pfizer Chief Business Officer John Young, testified: "We recognize that these are extraordinary times and our price will reflect that."
辉瑞 的意思是好歹赚点吧，但是也只是一点

既然圆桌上有分量的巨头都表态了，大家也都清楚了。资本嗜血，但是这种人类优先的情况下，谁都不愿意吃人血馒头，毕竟是现代社会的制药公司，面临的舆论压力还是挺大的。

国内挺有意思，老师们连个药瓶，瓶塞，注射器，冷链，冰箱都恨不得赚上一把，那么市场就会教吃人血馒头的老师们如何做人。